DexCom (DXCM) capital expenditure was $364M in FY2025 (+1% YoY). The tables below show the complete quarterly and annual capital expenditure history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Capital Expenditure
Fiscal Year
Capital Expenditure
YoY
2025
$364M
+1%
2024
$359M
+52%
2023
$237M
-35%
2022
$365M
-6%
2021
$389M
+96%
2020
$199M
+11%
2019
$180M
+168%
2018
$67M
+2%
2017
$66M
+18%
2016
$56M
+67%
2015
$33M
+106%
2014
$16M
+105%
2013
$8M
-17%
2012
$10M
+19%
2011
$8M
+16%
2010
$7M
+131%
2009
$3M
Recent Quarterly Capital Expenditure
Quarter
Capital Expenditure
Q1 2026
$77M
Q4 2025
$102M
Q3 2025
$80M
Q2 2025
$94M
Q1 2025
$87M
Q4 2024
$125M
Q3 2024
$111M
Q2 2024
$66M
Q1 2024
$57M
Q4 2023
$52M
Q3 2023
$50M
Q2 2023
$59M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.